Liquidia Corp (LQDA)
10.46
-0.52
(-4.74%)
USD |
NASDAQ |
Nov 04, 16:00
10.50
+0.04
(+0.38%)
After-Hours: 20:00
Liquidia Total Liabilities (Quarterly): 114.64M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 114.64M |
March 31, 2024 | 110.86M |
December 31, 2023 | 71.04M |
September 30, 2023 | 63.64M |
June 30, 2023 | 60.94M |
March 31, 2023 | 47.28M |
December 31, 2022 | 38.78M |
September 30, 2022 | 37.53M |
June 30, 2022 | 36.98M |
March 31, 2022 | 38.14M |
December 31, 2021 | 28.46M |
September 30, 2021 | 27.34M |
June 30, 2021 | 25.36M |
March 31, 2021 | 25.54M |
Date | Value |
---|---|
December 31, 2020 | 28.45M |
September 30, 2020 | 25.83M |
June 30, 2020 | 26.56M |
March 31, 2020 | 31.01M |
December 31, 2019 | 33.89M |
September 30, 2019 | 32.69M |
June 30, 2019 | 32.62M |
March 31, 2019 | 36.40M |
December 31, 2018 | 30.73M |
September 30, 2018 | 29.37M |
June 30, 2018 | 33.70M |
March 31, 2018 | 33.24M |
December 31, 2017 | 48.54M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
25.36M
Minimum
Jun 2021
114.64M
Maximum
Jun 2024
45.91M
Average
36.98M
Median
Jun 2022
Total Liabilities (Quarterly) Benchmarks
United Therapeutics Corp | 1.022B |
Arcturus Therapeutics Holdings Inc | 130.02M |
Paragon 28 Inc | 163.63M |
Tonix Pharmaceuticals Holding Corp | 28.20M |
AIM ImmunoTech Inc | 9.613M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 177.36M |
Shareholders Equity (Quarterly) | 62.72M |
Current Ratio | 6.080 |